PANADOLExtra (GlaxoSmithKline Consumer Healthcare Holdings (US) LLC)
Welcome to the PulseAid listing for the PANADOL drug offered from GlaxoSmithKline Consumer Healthcare Holdings (US) LLC. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
NON-PROPRIETARY NAME: | acetaminophen and caffeine |
SUBSTANCE NAME: | ACETAMINOPHEN; CAFFEINE |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | OTC MONOGRAPH NOT FINAL |
START MARKETING DATE: | 2017-03-01 |
END MARKETING DATE: | 0000-00-00 |
PANADOL Extra HUMAN OTC DRUG Details:
Item Description | PANADOL Extra from GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
LABELER NAME: | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 500; 65(mg/1; mg/1) |
START MARKETING DATE: | 2017-03-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0135-0620_e5c2d88a-d903-4ca0-b895-f27e791dfc4e |
PRODUCT NDC: | 0135-0620 |
APPLICATION NUMBER: | part343 |
Other ACETAMINOPHEN; CAFFEINE Pharmaceutical Manufacturers / Labelers: